. 2022 Dec 3;62(Suppl 2):S38–S55. doi: 10.1002/jcph.2134
© 2022 PTC Therapeutics Inc, Critical Path Institute and Pfizer Inc. The Journal of Clinical Pharmacology published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.